Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin

Keishi Yamasaki, Saya Hyodo, Kazuaki Taguchi, Koji Nishi, Noriyuki Yamaotsu, Shuichi Hirono, Victor Tuan Giam Chuang, Hakaru Seo, Toru Maruyama, Masaki Otagiri

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

A wide variety of drugs bind to human serum albumin (HSA) at its two principal sites, namely site I and site II.A number of reports indicate that drug binding to these two binding sites are not completely independent, and that interactions between ligands of these two discrete sites can play a role. In this study, the effect of the binding of long-chain fatty acids on the interactive binding between dansyl-L-asparagine (DNSA; site I ligand) and ibuprofen (site II ligand) at pH6.5 was examined. Binding experiments showed that the binding of sodium oleate (Ole) to HSA induces conformational changes in the molecule, which, in turn, changes the individual binding of DNSA and ibuprofen, as well as the mode of interaction between these two ligands from a 'competitive-like' allosteric interaction in the case of the defatted HSA conformer to a 'nearly independent' binding in the case of non-defatted HSA conformer. Circular dichroism measurements indicated that ibuprofen and Ole are likely to modify the spatial orientation of DNSA at its binding site. Docking simulations suggest that the long-distance electric repulsion between DNSA and ibuprofen on defatted HSA contributes to a 'competitive-like' allosteric interaction, whereas extending the distance between ligands and/or increasing the flexibility or size of the DNSA binding site in fatted HSA evokes a change in the interaction mode to 'nearly independent' binding. The present findings provide further insights into the structural dynamics of HSA upon the binding of fatty acids, and its effects on drug binding and drug-drug interactions that occur on HSA.

Original languageEnglish
Article numbere0180404
JournalPLoS One
Volume12
Issue number6
DOIs
Publication statusPublished - 2017 Jun 1
Externally publishedYes

Fingerprint

long chain fatty acids
Serum Albumin
binding sites
Fatty Acids
Binding Sites
ibuprofen
Ligands
drugs
Ibuprofen
Pharmaceutical Preparations
oleic acid
Drug interactions
circular dichroism spectroscopy
drug interactions
ligands
human serum albumin
Asparagine
Structural dynamics
asparagine
Oleic Acid

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Yamasaki, K., Hyodo, S., Taguchi, K., Nishi, K., Yamaotsu, N., Hirono, S., ... Otagiri, M. (2017). Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin. PLoS One, 12(6), [e0180404]. https://doi.org/10.1371/journal.pone.0180404

Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin. / Yamasaki, Keishi; Hyodo, Saya; Taguchi, Kazuaki; Nishi, Koji; Yamaotsu, Noriyuki; Hirono, Shuichi; Chuang, Victor Tuan Giam; Seo, Hakaru; Maruyama, Toru; Otagiri, Masaki.

In: PLoS One, Vol. 12, No. 6, e0180404, 01.06.2017.

Research output: Contribution to journalArticle

Yamasaki, K, Hyodo, S, Taguchi, K, Nishi, K, Yamaotsu, N, Hirono, S, Chuang, VTG, Seo, H, Maruyama, T & Otagiri, M 2017, 'Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin', PLoS One, vol. 12, no. 6, e0180404. https://doi.org/10.1371/journal.pone.0180404
Yamasaki, Keishi ; Hyodo, Saya ; Taguchi, Kazuaki ; Nishi, Koji ; Yamaotsu, Noriyuki ; Hirono, Shuichi ; Chuang, Victor Tuan Giam ; Seo, Hakaru ; Maruyama, Toru ; Otagiri, Masaki. / Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin. In: PLoS One. 2017 ; Vol. 12, No. 6.
@article{8f43f53106f0430fa41c3559719949a4,
title = "Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin",
abstract = "A wide variety of drugs bind to human serum albumin (HSA) at its two principal sites, namely site I and site II.A number of reports indicate that drug binding to these two binding sites are not completely independent, and that interactions between ligands of these two discrete sites can play a role. In this study, the effect of the binding of long-chain fatty acids on the interactive binding between dansyl-L-asparagine (DNSA; site I ligand) and ibuprofen (site II ligand) at pH6.5 was examined. Binding experiments showed that the binding of sodium oleate (Ole) to HSA induces conformational changes in the molecule, which, in turn, changes the individual binding of DNSA and ibuprofen, as well as the mode of interaction between these two ligands from a 'competitive-like' allosteric interaction in the case of the defatted HSA conformer to a 'nearly independent' binding in the case of non-defatted HSA conformer. Circular dichroism measurements indicated that ibuprofen and Ole are likely to modify the spatial orientation of DNSA at its binding site. Docking simulations suggest that the long-distance electric repulsion between DNSA and ibuprofen on defatted HSA contributes to a 'competitive-like' allosteric interaction, whereas extending the distance between ligands and/or increasing the flexibility or size of the DNSA binding site in fatted HSA evokes a change in the interaction mode to 'nearly independent' binding. The present findings provide further insights into the structural dynamics of HSA upon the binding of fatty acids, and its effects on drug binding and drug-drug interactions that occur on HSA.",
author = "Keishi Yamasaki and Saya Hyodo and Kazuaki Taguchi and Koji Nishi and Noriyuki Yamaotsu and Shuichi Hirono and Chuang, {Victor Tuan Giam} and Hakaru Seo and Toru Maruyama and Masaki Otagiri",
year = "2017",
month = "6",
day = "1",
doi = "10.1371/journal.pone.0180404",
language = "English",
volume = "12",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "6",

}

TY - JOUR

T1 - Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin

AU - Yamasaki, Keishi

AU - Hyodo, Saya

AU - Taguchi, Kazuaki

AU - Nishi, Koji

AU - Yamaotsu, Noriyuki

AU - Hirono, Shuichi

AU - Chuang, Victor Tuan Giam

AU - Seo, Hakaru

AU - Maruyama, Toru

AU - Otagiri, Masaki

PY - 2017/6/1

Y1 - 2017/6/1

N2 - A wide variety of drugs bind to human serum albumin (HSA) at its two principal sites, namely site I and site II.A number of reports indicate that drug binding to these two binding sites are not completely independent, and that interactions between ligands of these two discrete sites can play a role. In this study, the effect of the binding of long-chain fatty acids on the interactive binding between dansyl-L-asparagine (DNSA; site I ligand) and ibuprofen (site II ligand) at pH6.5 was examined. Binding experiments showed that the binding of sodium oleate (Ole) to HSA induces conformational changes in the molecule, which, in turn, changes the individual binding of DNSA and ibuprofen, as well as the mode of interaction between these two ligands from a 'competitive-like' allosteric interaction in the case of the defatted HSA conformer to a 'nearly independent' binding in the case of non-defatted HSA conformer. Circular dichroism measurements indicated that ibuprofen and Ole are likely to modify the spatial orientation of DNSA at its binding site. Docking simulations suggest that the long-distance electric repulsion between DNSA and ibuprofen on defatted HSA contributes to a 'competitive-like' allosteric interaction, whereas extending the distance between ligands and/or increasing the flexibility or size of the DNSA binding site in fatted HSA evokes a change in the interaction mode to 'nearly independent' binding. The present findings provide further insights into the structural dynamics of HSA upon the binding of fatty acids, and its effects on drug binding and drug-drug interactions that occur on HSA.

AB - A wide variety of drugs bind to human serum albumin (HSA) at its two principal sites, namely site I and site II.A number of reports indicate that drug binding to these two binding sites are not completely independent, and that interactions between ligands of these two discrete sites can play a role. In this study, the effect of the binding of long-chain fatty acids on the interactive binding between dansyl-L-asparagine (DNSA; site I ligand) and ibuprofen (site II ligand) at pH6.5 was examined. Binding experiments showed that the binding of sodium oleate (Ole) to HSA induces conformational changes in the molecule, which, in turn, changes the individual binding of DNSA and ibuprofen, as well as the mode of interaction between these two ligands from a 'competitive-like' allosteric interaction in the case of the defatted HSA conformer to a 'nearly independent' binding in the case of non-defatted HSA conformer. Circular dichroism measurements indicated that ibuprofen and Ole are likely to modify the spatial orientation of DNSA at its binding site. Docking simulations suggest that the long-distance electric repulsion between DNSA and ibuprofen on defatted HSA contributes to a 'competitive-like' allosteric interaction, whereas extending the distance between ligands and/or increasing the flexibility or size of the DNSA binding site in fatted HSA evokes a change in the interaction mode to 'nearly independent' binding. The present findings provide further insights into the structural dynamics of HSA upon the binding of fatty acids, and its effects on drug binding and drug-drug interactions that occur on HSA.

UR - http://www.scopus.com/inward/record.url?scp=85021667327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021667327&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0180404

DO - 10.1371/journal.pone.0180404

M3 - Article

C2 - 28662200

AN - SCOPUS:85021667327

VL - 12

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 6

M1 - e0180404

ER -